To further understand the role of RBMX in chemotherapy resistance and cancer prognosis of T-cell lymphomas, the present study investigates the immunohistochemical protein expression of RBMX in combination with the clinical outcomes in patients with T-NHL. Here, RBMX is linked to cancer.